🔓 Unlock the full profile of Tasuku Kitada (Strand Therapeutics), including verified contact details, financial insights, and professional associations.
See Tasuku Kitada Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: tas*****@str******.com
Mobile: 66061*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Tasuku Kitada is a co-founder, board director, president, and head of R&D at Strand Therapeutics, which was founded in 2017 and is located in Boston, Massachusetts.
- Strand Therapeutics focuses on developing RNA therapeutics aimed at providing innovative treatments for various diseases, utilizing advanced synthetic biology techniques.
- Since starting at Strand Therapeutics in December 2018, Tasuku Kitada has played a pivotal role in the direction and advancement of the company's research and development efforts.
- Prior to joining Strand, Tasuku Kitada served as a senior biotechnology analyst at Candriam from November 2015, contributing expertise in evaluating biotechnology investments.
- Tasuku Kitada's background includes postdoctoral research positions at prestigious institutions like MIT and UCLA, enhancing expertise in the field of biotechnology.
- At MIT, the individual worked as a postdoctoral associate, contributing to innovative research projects from October 2012 until December 2015.
- During the tenure at UCLA, serving as a postdoctoral scholar from September 2011 to October 2012, further foundational skills and knowledge in biotechnology were established.
- Under the leadership of Tasuku Kitada, Strand Therapeutics has seen steady growth, evidenced by a recent increase in headcount over the past year.
- Strand Therapeutics has embraced a commitment to advancing industry standards in RNA-based therapies, aiming to drive significant improvements in patient outcomes through targeted treatments.